|
||||||
|
 | Fusion Gene Summary |
| Fusion Gene ORF analysis |
| Fusion Genomic Features |
| Fusion Protein Features |
| Fusion Gene Sequence |
| Fusion Gene PPI analysis |
| Related Drugs |
| Related Diseases |
Fusion gene:GLOD4-EIF5A (FusionGDB2 ID:33214) |
Fusion Gene Summary for GLOD4-EIF5A |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: GLOD4-EIF5A | Fusion gene ID: 33214 | Hgene | Tgene | Gene symbol | GLOD4 | EIF5A | Gene ID | 51031 | 143244 |
| Gene name | glyoxalase domain containing 4 | eukaryotic translation initiation factor 5A like 1 | |
| Synonyms | C17orf25|CGI-150|HC71 | EIF5A|EIF5AP1|bA342M3.3|eIF-4D|eIF-5A|eIF-5A-1|eIF-5A1 | |
| Cytomap | 17p13.3 | 10q22.3 | |
| Type of gene | protein-coding | protein-coding | |
| Description | glyoxalase domain-containing protein 4 | eukaryotic translation initiation factor 5A-1-likeEukaryotic translation initiation factor 5A-1Rev-binding factoreukaryotic translation initiation factor 5A pseudogene 1 | |
| Modification date | 20200313 | 20200313 | |
| UniProtAcc | Q9HC38 | Q6IS14 | |
| Ensembl transtripts involved in fusion gene | ENST00000575800, ENST00000301329, ENST00000301328, ENST00000536578, | ENST00000336452, ENST00000336458, ENST00000576930, ENST00000572815, ENST00000573542, ENST00000419711, ENST00000571955, ENST00000416016, | |
| Fusion gene scores | * DoF score | 4 X 4 X 3=48 | 9 X 5 X 8=360 |
| # samples | 5 | 9 | |
| ** MAII score | log2(5/48*10)=0.0588936890535686 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | log2(9/360*10)=-2 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
| Context | PubMed: GLOD4 [Title/Abstract] AND EIF5A [Title/Abstract] AND fusion [Title/Abstract] | ||
| Most frequent breakpoint | GLOD4(673109)-EIF5A(7212934), # samples:2 | ||
| Anticipated loss of major functional domain due to fusion event. | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Fusion gene breakpoints across GLOD4 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
| Fusion gene breakpoints across EIF5A (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
| Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| ChimerDB4 | CHOL | TCGA-W5-AA31-01A | GLOD4 | chr17 | 673109 | - | EIF5A | chr17 | 7212934 | + |
| ChimerDB4 | CHOL | TCGA-W5-AA31-01A | GLOD4 | chr17 | 673109 | - | EIF5A | chr17 | 7212934 | + |
Top |
Fusion Gene ORF analysis for GLOD4-EIF5A |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| intron-3CDS | ENST00000575800 | ENST00000336452 | GLOD4 | chr17 | 673109 | - | EIF5A | chr17 | 7212934 | + |
| intron-5UTR | ENST00000575800 | ENST00000336458 | GLOD4 | chr17 | 673109 | - | EIF5A | chr17 | 7212934 | + |
| intron-5UTR | ENST00000575800 | ENST00000576930 | GLOD4 | chr17 | 673109 | - | EIF5A | chr17 | 7212934 | + |
| intron-5UTR | ENST00000575800 | ENST00000572815 | GLOD4 | chr17 | 673109 | - | EIF5A | chr17 | 7212934 | + |
| intron-5UTR | ENST00000575800 | ENST00000573542 | GLOD4 | chr17 | 673109 | - | EIF5A | chr17 | 7212934 | + |
| intron-5UTR | ENST00000575800 | ENST00000419711 | GLOD4 | chr17 | 673109 | - | EIF5A | chr17 | 7212934 | + |
| intron-5UTR | ENST00000575800 | ENST00000571955 | GLOD4 | chr17 | 673109 | - | EIF5A | chr17 | 7212934 | + |
| intron-5UTR | ENST00000575800 | ENST00000416016 | GLOD4 | chr17 | 673109 | - | EIF5A | chr17 | 7212934 | + |
| In-frame | ENST00000301329 | ENST00000336452 | GLOD4 | chr17 | 673109 | - | EIF5A | chr17 | 7212934 | + |
| 5CDS-5UTR | ENST00000301329 | ENST00000336458 | GLOD4 | chr17 | 673109 | - | EIF5A | chr17 | 7212934 | + |
| 5CDS-5UTR | ENST00000301329 | ENST00000576930 | GLOD4 | chr17 | 673109 | - | EIF5A | chr17 | 7212934 | + |
| 5CDS-5UTR | ENST00000301329 | ENST00000572815 | GLOD4 | chr17 | 673109 | - | EIF5A | chr17 | 7212934 | + |
| 5CDS-5UTR | ENST00000301329 | ENST00000573542 | GLOD4 | chr17 | 673109 | - | EIF5A | chr17 | 7212934 | + |
| 5CDS-5UTR | ENST00000301329 | ENST00000419711 | GLOD4 | chr17 | 673109 | - | EIF5A | chr17 | 7212934 | + |
| 5CDS-5UTR | ENST00000301329 | ENST00000571955 | GLOD4 | chr17 | 673109 | - | EIF5A | chr17 | 7212934 | + |
| 5CDS-5UTR | ENST00000301329 | ENST00000416016 | GLOD4 | chr17 | 673109 | - | EIF5A | chr17 | 7212934 | + |
| In-frame | ENST00000301328 | ENST00000336452 | GLOD4 | chr17 | 673109 | - | EIF5A | chr17 | 7212934 | + |
| 5CDS-5UTR | ENST00000301328 | ENST00000336458 | GLOD4 | chr17 | 673109 | - | EIF5A | chr17 | 7212934 | + |
| 5CDS-5UTR | ENST00000301328 | ENST00000576930 | GLOD4 | chr17 | 673109 | - | EIF5A | chr17 | 7212934 | + |
| 5CDS-5UTR | ENST00000301328 | ENST00000572815 | GLOD4 | chr17 | 673109 | - | EIF5A | chr17 | 7212934 | + |
| 5CDS-5UTR | ENST00000301328 | ENST00000573542 | GLOD4 | chr17 | 673109 | - | EIF5A | chr17 | 7212934 | + |
| 5CDS-5UTR | ENST00000301328 | ENST00000419711 | GLOD4 | chr17 | 673109 | - | EIF5A | chr17 | 7212934 | + |
| 5CDS-5UTR | ENST00000301328 | ENST00000571955 | GLOD4 | chr17 | 673109 | - | EIF5A | chr17 | 7212934 | + |
| 5CDS-5UTR | ENST00000301328 | ENST00000416016 | GLOD4 | chr17 | 673109 | - | EIF5A | chr17 | 7212934 | + |
| In-frame | ENST00000536578 | ENST00000336452 | GLOD4 | chr17 | 673109 | - | EIF5A | chr17 | 7212934 | + |
| 5CDS-5UTR | ENST00000536578 | ENST00000336458 | GLOD4 | chr17 | 673109 | - | EIF5A | chr17 | 7212934 | + |
| 5CDS-5UTR | ENST00000536578 | ENST00000576930 | GLOD4 | chr17 | 673109 | - | EIF5A | chr17 | 7212934 | + |
| 5CDS-5UTR | ENST00000536578 | ENST00000572815 | GLOD4 | chr17 | 673109 | - | EIF5A | chr17 | 7212934 | + |
| 5CDS-5UTR | ENST00000536578 | ENST00000573542 | GLOD4 | chr17 | 673109 | - | EIF5A | chr17 | 7212934 | + |
| 5CDS-5UTR | ENST00000536578 | ENST00000419711 | GLOD4 | chr17 | 673109 | - | EIF5A | chr17 | 7212934 | + |
| 5CDS-5UTR | ENST00000536578 | ENST00000571955 | GLOD4 | chr17 | 673109 | - | EIF5A | chr17 | 7212934 | + |
| 5CDS-5UTR | ENST00000536578 | ENST00000416016 | GLOD4 | chr17 | 673109 | - | EIF5A | chr17 | 7212934 | + |
| ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
| ENST00000301329 | GLOD4 | chr17 | 673109 | - | ENST00000336452 | EIF5A | chr17 | 7212934 | + | 2048 | 917 | 68 | 1402 | 444 |
| ENST00000301328 | GLOD4 | chr17 | 673109 | - | ENST00000336452 | EIF5A | chr17 | 7212934 | + | 2031 | 900 | 6 | 1385 | 459 |
| ENST00000536578 | GLOD4 | chr17 | 673109 | - | ENST00000336452 | EIF5A | chr17 | 7212934 | + | 2228 | 1097 | 239 | 1582 | 447 |
| DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
| ENST00000301329 | ENST00000336452 | GLOD4 | chr17 | 673109 | - | EIF5A | chr17 | 7212934 | + | 0.001798081 | 0.99820185 |
| ENST00000301328 | ENST00000336452 | GLOD4 | chr17 | 673109 | - | EIF5A | chr17 | 7212934 | + | 0.002308189 | 0.99769187 |
| ENST00000536578 | ENST00000336452 | GLOD4 | chr17 | 673109 | - | EIF5A | chr17 | 7212934 | + | 0.001160273 | 0.9988398 |
Top |
Fusion Genomic Features for GLOD4-EIF5A |
| FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
| Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
| GLOD4 | chr17 | 673108 | - | EIF5A | chr17 | 7212933 | + | 7.34E-08 | 0.9999999 |
| GLOD4 | chr17 | 673108 | - | EIF5A | chr17 | 7212933 | + | 7.34E-08 | 0.9999999 |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
Top |
Fusion Protein Features for GLOD4-EIF5A |
| Go to FGviewer for the breakpoints of chr17:673109-chr17:7212934 - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. |
 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| GLOD4 | EIF5A |
| FUNCTION: mRNA-binding protein involved in translation elongation. Has an important function at the level of mRNA turnover, probably acting downstream of decapping. Involved in actin dynamics and cell cycle progression, mRNA decay and probably in a pathway involved in stress response and maintenance of cell wall integrity. Functions as a regulator of apoptosis. Mediates effects of polyamines on neuronal process extension and survival. May play an important role in brain development and function, and in skeletal muscle stem cell differentiation (By similarity). {ECO:0000250}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Hgene | GLOD4 | chr17:673109 | chr17:7212934 | ENST00000301328 | - | 9 | 10 | 152_273 | 292.0 | 314.0 | Domain | VOC 2 |
| Hgene | GLOD4 | chr17:673109 | chr17:7212934 | ENST00000301328 | - | 9 | 10 | 5_145 | 292.0 | 314.0 | Domain | VOC 1 |
| Hgene | GLOD4 | chr17:673109 | chr17:7212934 | ENST00000301329 | - | 8 | 9 | 152_273 | 277.0 | 299.0 | Domain | VOC 2 |
| Hgene | GLOD4 | chr17:673109 | chr17:7212934 | ENST00000301329 | - | 8 | 9 | 5_145 | 277.0 | 299.0 | Domain | VOC 1 |
| Tgene | EIF5A | chr17:673109 | chr17:7212934 | ENST00000336452 | 0 | 6 | 20_90 | 23.0 | 357.3333333333333 | Region | Note=DOHH-binding | |
| Tgene | EIF5A | chr17:673109 | chr17:7212934 | ENST00000336458 | 0 | 6 | 20_90 | 0 | 239.66666666666666 | Region | Note=DOHH-binding | |
| Tgene | EIF5A | chr17:673109 | chr17:7212934 | ENST00000416016 | 0 | 6 | 20_90 | 0 | 298.0 | Region | Note=DOHH-binding | |
| Tgene | EIF5A | chr17:673109 | chr17:7212934 | ENST00000419711 | 0 | 6 | 20_90 | 0 | 319.6666666666667 | Region | Note=DOHH-binding | |
| Tgene | EIF5A | chr17:673109 | chr17:7212934 | ENST00000571955 | 1 | 7 | 20_90 | 0 | 319.6666666666667 | Region | Note=DOHH-binding | |
| Tgene | EIF5A | chr17:673109 | chr17:7212934 | ENST00000573542 | 0 | 6 | 20_90 | 0 | 245.66666666666666 | Region | Note=DOHH-binding | |
| Tgene | EIF5A | chr17:673109 | chr17:7212934 | ENST00000576930 | 1 | 7 | 20_90 | 0 | 295.3333333333333 | Region | Note=DOHH-binding |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
Fusion Gene Sequence for GLOD4-EIF5A |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
| >In-frame_ENST00000301329_ENST00000336452_TCGA-W5-AA31-01A_GLOD4_chr17_673109_-_EIF5A_chr17_7212934_length(transcript)=2048nt_BP=917nt GTCGGCGGCTAGTGACGTCACGGCCCGTGGCGCCCTTCGTGGACTGGGCTGTACGGTGCGCGTGACGGCTGCGTGCGGCGGGAATCATGG CTGCTCGCAGAGCTCTGCACTTCGTATTCAAAGTGGGAAACCGCTTCCAGACGGCGCGTTTCTATCGGGACGTCCTGGGGATGAAGGTTC TGCGGCATGAGGAATTTGAAGAAGGCTGCAAAGCTGCCTGTAATGGGCCTTATGATGGGAAATGGAGTAAAACAATGGTGGGATTTGGGC CTGAGGATGATCATTTTGTCGCAGAACTGACTTACAATTATGGCGTCGGAGACTACAAGCTTGGCAATGACTTTATGGGAATCACGCTCG CTTCTAGCCAGGCTGTCAGCAACGCCAGGAAGCTGGAGTGGCCACTGACGGAAGTTGCAGAAGGTGTTTTTGAAACCGAGGCCCCGGGAG GATATAAGTTCTATTTGCAGAATCGCAGTCTGCCTCAGTCAGATCCTGTATTAAAAGTAACTCTAGCAGTGTCTGATCTTCAAAAGTCCT TGAACTACTGGTGTAATCTACTGGGAATGAAAATTTATGAAAAAGATGAAGAAAAGCAAAGGGCTTTGCTGGGCTATGCTGATAACCAGT GTAAGCTGGAGCTACAGGGCGTCAAGGGTGGGGTGGACCATGCAGCAGCTTTTGGAAGAATTGCCTTCTCTTGCCCCCAGAAAGAGTTGC CAGACTTAGAAGACTTGATGAAAAGGGAGAACCAGAAGATTCTGACTCCCCTGGTGAGCCTGGACACCCCAGGGAAAGCAACAGTACAGG TGGTCATTCTGGCCGACCCTGACGGACATGAAATTTGCTTTGTCGGGGATGAAGCATTTCGAGAACTTTCTAAGATGGATCCAGAGGGAA GCAAATTGTTGGATGATTTGGAATCGAAGCCTCTTAAAATGGCAGATGACTTGGACTTCGAGACAGGAGATGCAGGGGCCTCAGCCACCT TCCCAATGCAGTGCTCAGCATTACGTAAGAATGGCTTTGTGGTGCTCAAAGGCCGGCCATGTAAGATCGTCGAGATGTCTACTTCGAAGA CTGGCAAGCACGGCCACGCCAAGGTCCATCTGGTTGGTATTGACATCTTTACTGGGAAGAAATATGAAGATATCTGCCCGTCAACTCATA ATATGGATGTCCCCAACATCAAAAGGAATGACTTCCAGCTGATTGGCATCCAGGATGGGTACCTATCACTGCTCCAGGACAGCGGGGAGG TACGAGAGGACCTTCGTCTCCCTGAGGGAGACCTTGGCAAGGAGATTGAGCAGAAGTACGACTGTGGAGAAGAGATCCTGATCACGGTGC TGTCTGCCATGACAGAGGAGGCAGCTGTTGCAATCAAGGCCATGGCAAAATAACTGGCTCCCAGGGTGGCGGTGGTGGCAGCAGTGATCC TCTGAACCTGCAGAGGCCCCCTCCCCGAGCCTGGCCTGGCTCTGGCCCGGTCCTAAGCTGGACTCCTCCTACACAATTTATTTGACGTTT TATTTTGGTTTTCCCCACCCCCTCAATCTGTCGGGGAGCCCCTGCCCTTCACCTAGCTCCCTTGGCCAGGAGCGAGCGAAGCTGTGGCCT TGGTGAAGCTGCCCTCCTCTTCTCCCCTCACACTACAGCCCTGGTGGGGGAGAAGGGGGTGGGTGCTGCTTGTGGTTTAGTCTTTTTTTT TTTTTTTTTTTTAATTCAATCTGGAATCAGAAAGCGGTGGATTCTGGCAAATGGTCCTTGTGCCCTCCCCACTCATCCCTGGTCTGGTCC CCTGTTGCCTATAGCCCTTTACCCTGAGCACCACCCCAACAGACTGGGGACCAGCCCCCTCGCCTGCCTGTGTCTCTCCCCAAACCCCTT TAGATGGGGAGGGAAGAGGAGGAGAGGGGAGGGGACCTGCCCCCTCCTCAGGCATCTGGGAGGGCCCTGCCCCCATGGGCTTTACCCTTC >In-frame_ENST00000301329_ENST00000336452_TCGA-W5-AA31-01A_GLOD4_chr17_673109_-_EIF5A_chr17_7212934_length(amino acids)=444AA_start in transcript=68_stop in transcript=1402 MRAAGIMAARRALHFVFKVGNRFQTARFYRDVLGMKVLRHEEFEEGCKAACNGPYDGKWSKTMVGFGPEDDHFVAELTYNYGVGDYKLGN DFMGITLASSQAVSNARKLEWPLTEVAEGVFETEAPGGYKFYLQNRSLPQSDPVLKVTLAVSDLQKSLNYWCNLLGMKIYEKDEEKQRAL LGYADNQCKLELQGVKGGVDHAAAFGRIAFSCPQKELPDLEDLMKRENQKILTPLVSLDTPGKATVQVVILADPDGHEICFVGDEAFREL SKMDPEGSKLLDDLESKPLKMADDLDFETGDAGASATFPMQCSALRKNGFVVLKGRPCKIVEMSTSKTGKHGHAKVHLVGIDIFTGKKYE -------------------------------------------------------------- >In-frame_ENST00000301328_ENST00000336452_TCGA-W5-AA31-01A_GLOD4_chr17_673109_-_EIF5A_chr17_7212934_length(transcript)=2031nt_BP=900nt TGACGGCTGCGTGCGGCGGGAATCATGGCTGCTCGCAGAGCTCTGCACTTCGTATTCAAAGTGGGAAACCGCTTCCAGACGGCGCGTTTC TATCGGGACGTCCTGGGGATGAAGGTGGAGTCTTGCTCTGTCGCCAGGCTGGAGTGCAGTGGCGCGATCTCGGCTCACTGCTCTGACTAC ACCCGGATAACAGAAGACAGTTTCTCAAAGCCTTATGATGGGAAATGGAGTAAAACAATGGTGGGATTTGGGCCTGAGGATGATCATTTT GTCGCAGAACTGACTTACAATTATGGCGTCGGAGACTACAAGCTTGGCAATGACTTTATGGGAATCACGCTCGCTTCTAGCCAGGCTGTC AGCAACGCCAGGAAGCTGGAGTGGCCACTGACGGAAGTTGCAGAAGGTGTTTTTGAAACCGAGGCCCCGGGAGGATATAAGTTCTATTTG CAGAATCGCAGTCTGCCTCAGTCAGATCCTGTATTAAAAGTAACTCTAGCAGTGTCTGATCTTCAAAAGTCCTTGAACTACTGGTGTAAT CTACTGGGAATGAAAATTTATGAAAAAGATGAAGAAAAGCAAAGGGCTTTGCTGGGCTATGCTGATAACCAGTGTAAGCTGGAGCTACAG GGCGTCAAGGGTGGGGTGGACCATGCAGCAGCTTTTGGAAGAATTGCCTTCTCTTGCCCCCAGAAAGAGTTGCCAGACTTAGAAGACTTG ATGAAAAGGGAGAACCAGAAGATTCTGACTCCCCTGGTGAGCCTGGACACCCCAGGGAAAGCAACAGTACAGGTGGTCATTCTGGCCGAC CCTGACGGACATGAAATTTGCTTTGTCGGGGATGAAGCATTTCGAGAACTTTCTAAGATGGATCCAGAGGGAAGCAAATTGTTGGATGAT TTGGAATCGAAGCCTCTTAAAATGGCAGATGACTTGGACTTCGAGACAGGAGATGCAGGGGCCTCAGCCACCTTCCCAATGCAGTGCTCA GCATTACGTAAGAATGGCTTTGTGGTGCTCAAAGGCCGGCCATGTAAGATCGTCGAGATGTCTACTTCGAAGACTGGCAAGCACGGCCAC GCCAAGGTCCATCTGGTTGGTATTGACATCTTTACTGGGAAGAAATATGAAGATATCTGCCCGTCAACTCATAATATGGATGTCCCCAAC ATCAAAAGGAATGACTTCCAGCTGATTGGCATCCAGGATGGGTACCTATCACTGCTCCAGGACAGCGGGGAGGTACGAGAGGACCTTCGT CTCCCTGAGGGAGACCTTGGCAAGGAGATTGAGCAGAAGTACGACTGTGGAGAAGAGATCCTGATCACGGTGCTGTCTGCCATGACAGAG GAGGCAGCTGTTGCAATCAAGGCCATGGCAAAATAACTGGCTCCCAGGGTGGCGGTGGTGGCAGCAGTGATCCTCTGAACCTGCAGAGGC CCCCTCCCCGAGCCTGGCCTGGCTCTGGCCCGGTCCTAAGCTGGACTCCTCCTACACAATTTATTTGACGTTTTATTTTGGTTTTCCCCA CCCCCTCAATCTGTCGGGGAGCCCCTGCCCTTCACCTAGCTCCCTTGGCCAGGAGCGAGCGAAGCTGTGGCCTTGGTGAAGCTGCCCTCC TCTTCTCCCCTCACACTACAGCCCTGGTGGGGGAGAAGGGGGTGGGTGCTGCTTGTGGTTTAGTCTTTTTTTTTTTTTTTTTTTTAATTC AATCTGGAATCAGAAAGCGGTGGATTCTGGCAAATGGTCCTTGTGCCCTCCCCACTCATCCCTGGTCTGGTCCCCTGTTGCCTATAGCCC TTTACCCTGAGCACCACCCCAACAGACTGGGGACCAGCCCCCTCGCCTGCCTGTGTCTCTCCCCAAACCCCTTTAGATGGGGAGGGAAGA GGAGGAGAGGGGAGGGGACCTGCCCCCTCCTCAGGCATCTGGGAGGGCCCTGCCCCCATGGGCTTTACCCTTCCCTGCGGGCTCTCTCCC >In-frame_ENST00000301328_ENST00000336452_TCGA-W5-AA31-01A_GLOD4_chr17_673109_-_EIF5A_chr17_7212934_length(amino acids)=459AA_start in transcript=6_stop in transcript=1385 MRAAGIMAARRALHFVFKVGNRFQTARFYRDVLGMKVESCSVARLECSGAISAHCSDYTRITEDSFSKPYDGKWSKTMVGFGPEDDHFVA ELTYNYGVGDYKLGNDFMGITLASSQAVSNARKLEWPLTEVAEGVFETEAPGGYKFYLQNRSLPQSDPVLKVTLAVSDLQKSLNYWCNLL GMKIYEKDEEKQRALLGYADNQCKLELQGVKGGVDHAAAFGRIAFSCPQKELPDLEDLMKRENQKILTPLVSLDTPGKATVQVVILADPD GHEICFVGDEAFRELSKMDPEGSKLLDDLESKPLKMADDLDFETGDAGASATFPMQCSALRKNGFVVLKGRPCKIVEMSTSKTGKHGHAK VHLVGIDIFTGKKYEDICPSTHNMDVPNIKRNDFQLIGIQDGYLSLLQDSGEVREDLRLPEGDLGKEIEQKYDCGEEILITVLSAMTEEA -------------------------------------------------------------- >In-frame_ENST00000536578_ENST00000336452_TCGA-W5-AA31-01A_GLOD4_chr17_673109_-_EIF5A_chr17_7212934_length(transcript)=2228nt_BP=1097nt GCGGCGGGAATCATGGCTGCTCGCAGAGCTCTGCACTTCGTATTCAAAGTGGGAAACCGCTTCCAGACGGCGCGTTTCTATCGGGACGTC CTGGGGATGAAGGCCCTGCGCGGTGTTCAGCTTCAGGAGCGTGGCGAGTTGCCGTTGGGGATCATAGGCCTTGGAGAAGGGCCTAACACG ATTAGTCCCCGCGGTGTGCCCACGCACGTCCTTTCATTTAAGCCACTCGTAAACGTTTATTGAGCCCCGCCCTTGTGGAGCTTACCGTCT ACCGGAAAAGACGGTTCTGCGGCATGAGGAATTTGAAGAAGGCTGCAAAGCTGCCTGTAATGGGTATGATACCTTGTTTCTTAAAATCTC CTTTAGGCTCTGACTACACCCGGATAACAGAAGACAGTTTCTCAAAGCCTTATGATGGGAAATGGAGTAAAACAATGGTGGGATTTGGGC CTGAGGATGATCATTTTGTCGCAGAACTGACTTACAATTATGGCGTCGGAGACTACAAGCTTGGCAATGACTTTATGGGAATCACGCTCG CTTCTAGCCAGGCTGTCAGCAACGCCAGGAAGCTGGAGTGGCCACTGACGGAAGTTGCAGAAGGTGTTTTTGAAACCGAGGCCCCGGGAG GATATAAGTTCTATTTGCAGAATCGCAGTCTGCCTCAGTCAGATCCTGTATTAAAAGTAACTCTAGCAGTGTCTGATCTTCAAAAGTCCT TGAACTACTGGTGTAATCTACTGGGAATGAAAATTTATGAAAAAGATGAAGAAAAGCAAAGGGCTTTGCTGGGCTATGCTGATAACCAGT GTAAGCTGGAGCTACAGGGCGTCAAGGGTGGGGTGGACCATGCAGCAGCTTTTGGAAGAATTGCCTTCTCTTGCCCCCAGAAAGAGTTGC CAGACTTAGAAGACTTGATGAAAAGGGAGAACCAGAAGATTCTGACTCCCCTGGTGAGCCTGGACACCCCAGGGAAAGCAACAGTACAGG TGGTCATTCTGGCCGACCCTGACGGACATGAAATTTGCTTTGTCGGGGATGAAGCATTTCGAGAACTTTCTAAGATGGATCCAGAGGGAA GCAAATTGTTGGATGATTTGGAATCGAAGCCTCTTAAAATGGCAGATGACTTGGACTTCGAGACAGGAGATGCAGGGGCCTCAGCCACCT TCCCAATGCAGTGCTCAGCATTACGTAAGAATGGCTTTGTGGTGCTCAAAGGCCGGCCATGTAAGATCGTCGAGATGTCTACTTCGAAGA CTGGCAAGCACGGCCACGCCAAGGTCCATCTGGTTGGTATTGACATCTTTACTGGGAAGAAATATGAAGATATCTGCCCGTCAACTCATA ATATGGATGTCCCCAACATCAAAAGGAATGACTTCCAGCTGATTGGCATCCAGGATGGGTACCTATCACTGCTCCAGGACAGCGGGGAGG TACGAGAGGACCTTCGTCTCCCTGAGGGAGACCTTGGCAAGGAGATTGAGCAGAAGTACGACTGTGGAGAAGAGATCCTGATCACGGTGC TGTCTGCCATGACAGAGGAGGCAGCTGTTGCAATCAAGGCCATGGCAAAATAACTGGCTCCCAGGGTGGCGGTGGTGGCAGCAGTGATCC TCTGAACCTGCAGAGGCCCCCTCCCCGAGCCTGGCCTGGCTCTGGCCCGGTCCTAAGCTGGACTCCTCCTACACAATTTATTTGACGTTT TATTTTGGTTTTCCCCACCCCCTCAATCTGTCGGGGAGCCCCTGCCCTTCACCTAGCTCCCTTGGCCAGGAGCGAGCGAAGCTGTGGCCT TGGTGAAGCTGCCCTCCTCTTCTCCCCTCACACTACAGCCCTGGTGGGGGAGAAGGGGGTGGGTGCTGCTTGTGGTTTAGTCTTTTTTTT TTTTTTTTTTTTAATTCAATCTGGAATCAGAAAGCGGTGGATTCTGGCAAATGGTCCTTGTGCCCTCCCCACTCATCCCTGGTCTGGTCC CCTGTTGCCTATAGCCCTTTACCCTGAGCACCACCCCAACAGACTGGGGACCAGCCCCCTCGCCTGCCTGTGTCTCTCCCCAAACCCCTT TAGATGGGGAGGGAAGAGGAGGAGAGGGGAGGGGACCTGCCCCCTCCTCAGGCATCTGGGAGGGCCCTGCCCCCATGGGCTTTACCCTTC >In-frame_ENST00000536578_ENST00000336452_TCGA-W5-AA31-01A_GLOD4_chr17_673109_-_EIF5A_chr17_7212934_length(amino acids)=447AA_start in transcript=239_stop in transcript=1582 MSPALVELTVYRKRRFCGMRNLKKAAKLPVMGMIPCFLKSPLGSDYTRITEDSFSKPYDGKWSKTMVGFGPEDDHFVAELTYNYGVGDYK LGNDFMGITLASSQAVSNARKLEWPLTEVAEGVFETEAPGGYKFYLQNRSLPQSDPVLKVTLAVSDLQKSLNYWCNLLGMKIYEKDEEKQ RALLGYADNQCKLELQGVKGGVDHAAAFGRIAFSCPQKELPDLEDLMKRENQKILTPLVSLDTPGKATVQVVILADPDGHEICFVGDEAF RELSKMDPEGSKLLDDLESKPLKMADDLDFETGDAGASATFPMQCSALRKNGFVVLKGRPCKIVEMSTSKTGKHGHAKVHLVGIDIFTGK -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for GLOD4-EIF5A |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for GLOD4-EIF5A |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for GLOD4-EIF5A |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
| Tgene | EIF5A | C0007097 | Carcinoma | 1 | CTD_human |
| Tgene | EIF5A | C0022548 | Keloid | 1 | CTD_human |
| Tgene | EIF5A | C0024667 | Animal Mammary Neoplasms | 1 | CTD_human |
| Tgene | EIF5A | C0024668 | Mammary Neoplasms, Experimental | 1 | CTD_human |
| Tgene | EIF5A | C0205696 | Anaplastic carcinoma | 1 | CTD_human |
| Tgene | EIF5A | C0205697 | Carcinoma, Spindle-Cell | 1 | CTD_human |
| Tgene | EIF5A | C0205698 | Undifferentiated carcinoma | 1 | CTD_human |
| Tgene | EIF5A | C0205699 | Carcinomatosis | 1 | CTD_human |
| Tgene | EIF5A | C1257925 | Mammary Carcinoma, Animal | 1 | CTD_human |
Copyright 2021-Present -The University of Texas Health Science Center at Houston (UTHealth)
Web File Viewing | Emergency Information |Campus Carry|Site Policies